Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma

NCT06880198 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Melanoma Metastatic
Locally Advanced Melanoma

Interventions

DIETARY_SUPPLEMENT: Oral Impact®

Sponsor

Fondazione Melanoma Onlus